Brain Atrophy in Multiple Sclerosis: Therapeutic, Cognitive and Clinical Impact

Main Article Content

Juan Ignacio Rojas
Liliana Patrucco
Jimena Miguez
Edgardo Cristiano

Downloads

##plugins.themes.bootstrap3.displayStats.noStats##

Article Details

Section

Hospital Italiano in Medline

How to Cite

1.
Rojas JI, Patrucco L, Miguez J, Cristiano E. Brain Atrophy in Multiple Sclerosis: Therapeutic, Cognitive and Clinical Impact. Rev Hosp Ital B.Aires [Internet]. 2016 Sep. 30 [cited 2026 Jul. 31];36(3):109. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/664

References

Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med. 2000;343(13):938-52.

Cristiano E, Patrucco L, Rojas JI. A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol. 2008;15(12):1273-8.

Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol. 2008;7(3):268-77.

Río J, Nos C, Tintoré M, et al. Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients. Ann Neurol. 2006;59(2):344-52.

Filippi M, Valsasina P, Rocca M. Magnetic resonance imaging of grey matter damage in people with MS. Int MS J. 2007;14(1):12-21.

Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009;66(9):1144-50.

Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338(5):278-85.

Most read articles by the same author(s)